Role for Human Immunodeficiency Virus Type 1 Tat Protein in Suppression of Viral Reverse Transcriptase Activity during Late Stages of Viral Replication

ABSTRACT We have examined the role of the human immunodeficiency virus type 1 (HIV-1) Tat protein in the regulation of reverse transcription. We show that a two-exon but not a one-exon form of Tat markedly suppressed cell-free reverse transcriptase (RT) activity. Conversely, viruses expressing two-exon Tat (pNL43 and pNL101) showed rapid replication kinetics and more efficient endogenous RT activity compared with viruses expressing one-exon Tat (pM1ex). The pM1ex virions, as well as pM1ex-infected cells, also contained higher levels of viral DNA than did either the pNL43 or pNL101 viruses, indicating that reverse transcription might have continued during later stages of viral replication in the absence of the second Tat exon. Moreover, degradation of viral genomic RNA was more apparent in the pM1ex virions. Accordingly, we propose that the two-exon Tat may help augment viral infectivity by suppressing the reverse transcription reaction during late stages of viral synthesis and by preventing the synthesis of potentially deleterious viral DNA products.

[1]  M. Wainberg,et al.  Human immunodeficiency virus type-1 reverse transcription can be inhibited in vitro by oligonucleotides that target both natural and synthetic tRNA primers. , 2000, Nucleic acids research.

[2]  Hui Zhang,et al.  Partial Rescue of the Vif-Negative Phenotype of Mutant Human Immunodeficiency Virus Type 1 Strains from Nonpermissive Cells by Intravirion Reverse Transcription , 2000, Journal of Virology.

[3]  F. Kashanchi,et al.  Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator , 2000, Journal of Virology.

[4]  K. Jeang,et al.  Multifaceted Activities of the HIV-1 Transactivator of Transcription, Tat* , 1999, The Journal of Biological Chemistry.

[5]  M. Kameoka,et al.  HIV-1 Tat protein is poly(ADP-ribosyl)ated in vitro. , 1999, Biochemical and biophysical research communications.

[6]  C. Ehresmann,et al.  The Human Immunodeficiency Virus Type 1 Gag Polyprotein Has Nucleic Acid Chaperone Activity: Possible Role in Dimerization of Genomic RNA and Placement of tRNA on the Primer Binding Site , 1999, Journal of Virology.

[7]  M. Wainberg,et al.  The Role of Pr55gag in the Annealing of tRNA3Lys to Human Immunodeficiency Virus Type 1 Genomic RNA , 1999, Journal of Virology.

[8]  R. Gaynor,et al.  Functional Domains of Tat Required for Efficient Human Immunodeficiency Virus Type 1 Reverse Transcription , 1999, Journal of Virology.

[9]  R. Stauber,et al.  Intracellular trafficking and interactions of the HIV-1 Tat protein. , 1998, Virology.

[10]  M. Wainberg,et al.  Dominance of the E89G Substitution in HIV-1 Reverse Transcriptase in Regard to Increased Polymerase Processivity and Patterns of Pausing* , 1998, The Journal of Biological Chemistry.

[11]  G. Morris,et al.  Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. , 1997, Virology.

[12]  R. Bambara,et al.  Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer* , 1997, The Journal of Biological Chemistry.

[13]  C. Gabus,et al.  Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. , 1997, Journal of molecular biology.

[14]  R. Gaynor,et al.  Tat is required for efficient HIV‐1 reverse transcription , 1997, The EMBO journal.

[15]  C. Van Lint,et al.  Immune Hyperactivation of HIV-1-Infected T Cells Mediated by Tat and the CD28 Pathway , 1997, Science.

[16]  C. Ehresmann,et al.  Binding and kinetic properties of HIV‐1 reverse transcriptase markedly differ during initiation and elongation of reverse transcription. , 1996, The EMBO journal.

[17]  B. Berkhout,et al.  Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.

[18]  K. Jeang,et al.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture , 1996, Journal of virology.

[19]  M. Wainberg,et al.  Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site , 1996, Journal of virology.

[20]  M. Tius,et al.  Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[21]  C. Ehresmann,et al.  Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post‐transcriptional modifications of primer tRNA3Lys. , 1996, The EMBO journal.

[22]  B. Roques,et al.  First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.

[23]  T. Masuda,et al.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain , 1995, Journal of virology.

[24]  D. Trono,et al.  Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis , 1995, Journal of virology.

[25]  O. Danos,et al.  Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell , 1995, Journal of virology.

[26]  T. Andoh,et al.  Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[28]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[29]  K. Jeang,et al.  Human immunodeficiency viruses regulated by alternative trans‐activators: genetic evidence for a novel non‐transcriptional function of Tat in virion infectivity. , 1994, The EMBO journal.

[30]  M. Wainberg,et al.  Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. , 1994, The Journal of biological chemistry.

[31]  T. Spicer,et al.  Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance. , 1993, AIDS research and human retroviruses.

[32]  B. Berkhout,et al.  Effects of integration and replication on transcription of the HIV-1 long terminal repeat. , 1993, The Journal of biological chemistry.

[33]  D. Trono,et al.  Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells , 1993, Journal of virology.

[34]  Y. Kim,et al.  The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression , 1993, Journal of virology.

[35]  J. Mak,et al.  Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 , 1993, Journal of virology.

[36]  D. Dimitrov,et al.  Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.

[37]  M Chowdhury,et al.  TAR‐independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV‐1 gene regulation. , 1992, The EMBO journal.

[38]  D. Trono,et al.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses , 1992, Journal of virology.

[39]  F. Lori,et al.  Viral DNA carried by human immunodeficiency virus type 1 virions , 1992, Journal of virology.

[40]  M. Emerman,et al.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene , 1992, Journal of virology.

[41]  T. Chang,et al.  Identification and characterization of human immunodeficiency virus type 1 gag-pol fusion protein in transfected mammalian cells , 1991, Journal of virology.

[42]  S. Segal,et al.  Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core. , 1990, The EMBO journal.

[43]  M. Singh,et al.  HIV‐1 tat protein stimulates transcription by binding to a U‐rich bulge in the stem of the TAR RNA structure. , 1990, The EMBO journal.

[44]  S. Salahuddin,et al.  Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.

[45]  M. Stevenson,et al.  HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.

[46]  A. Fauci,et al.  Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. , 1989, Journal of immunology.

[47]  D. Bredt,et al.  Tat protein from human immunodeficiency virus forms a metal-linked dimer. , 1988, Science.

[48]  H. Gendelman,et al.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.

[49]  Mark L. Pearson,et al.  Complete nucleotide sequence of the AIDS virus, HTLV-III , 1985, Nature.

[50]  A. Rein,et al.  Murine leukemia virus mutant with a frameshift in the reverse transcriptase coding region: implications for pol gene structure , 1984, Journal of virology.

[51]  R. Gallo,et al.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. , 1984, Science.

[52]  R. Bambara,et al.  Inhibition of HIV-1 Replication Using a Mutated tRNA Primer* , 1997 .

[53]  S. Goff,et al.  Reverse Transcriptase and the Generation of Retroviral DNA , 1997 .

[54]  B. Peterlin,et al.  Control of RNA initiation and elongation at the HIV-1 promoter. , 1994, Annual review of biochemistry.

[55]  S. L. Le Grice,et al.  Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. , 1990, European journal of biochemistry.

[56]  F. Lori,et al.  Enzymatically active forms of reverse transcriptase of the human immunodeficiency virus. , 1988, AIDS research and human retroviruses.

[57]  T. A. Hagan,et al.  Detection , Isolation , and Continuous Production of Cytopathic Retroviruses ( HTLV-III ) from Patients with AIDS and Pre-AIDS , 2022 .